Filing Details
- Accession Number:
- 0001140361-18-022697
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-10 11:27:25
- Reporting Period:
- 2018-05-09
- Accepted Time:
- 2018-05-10 11:27:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 70487 | National Research Corp | NRCI | Services-Commercial Physical & Biological Research (8731) | 470634000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1248110 | N John Nunnelly | P.o. Box 2175 Amherst MA 01004 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-05-09 | 15,029 | $14.19 | 66,923 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-05-09 | 6,375 | $33.45 | 60,548 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2018-05-09 | 8,654 | $33.31 | 51,894 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Director Stock Option (Right to Buy) | Disposition | 2018-05-09 | 15,029 | $0.00 | 15,029 | $14.19 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 12,310 | 2017-05-11 | 2026-05-11 | No | 4 | M | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Director Stock Option (Right to Buy) | $9.73 | 2012-05-06 | 2021-05-06 | 28,763 | 28,763 | Direct |
| Common Stock | Director Stock Option (Right to Buy) | $16.89 | 2014-05-09 | 2023-05-09 | 36,000 | 36,000 | Direct |
| Common Stock | Director Stock Option (Right to Buy) | $14.95 | 2015-05-08 | 2024-05-08 | 36,000 | 36,000 | Direct |
| Common Stock | Director Stock Option (Right to Buy) | $14.21 | 2016-05-07 | 2025-05-07 | 36,000 | 36,000 | Direct |
| Common Stock | Director Stock Option (Right to Buy) | $24.35 | 2018-05-09 | 2027-05-09 | 36,000 | 36,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2021-05-06 | 28,763 | 28,763 | Direct |
| 2023-05-09 | 36,000 | 36,000 | Direct |
| 2024-05-08 | 36,000 | 36,000 | Direct |
| 2025-05-07 | 36,000 | 36,000 | Direct |
| 2027-05-09 | 36,000 | 36,000 | Direct |
Footnotes
- The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 29, 2018.
- The price in Column 4 is a weighted average price. The prices actually received ranged from $33.05 to $33.65. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
Billionaire Hedge Funds
